Digoxin
CAS No. 20830-75-5
Digoxin ( 12β-Hydroxydigitoxin )
产品货号. M19518 CAS No. 20830-75-5
Digoxin is occasionally used in the treatment of various heart conditions namely atrial fibrillation atrial flutter and sometimes heart failure that cannot be controlled by other medication.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Digoxin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Digoxin is occasionally used in the treatment of various heart conditions namely atrial fibrillation atrial flutter and sometimes heart failure that cannot be controlled by other medication.
-
产品描述Digoxin is occasionally used in the treatment of various heart conditions namely atrial fibrillation atrial flutter and sometimes heart failure that cannot be controlled by other medication.
-
同义词12β-Hydroxydigitoxin
-
通路Endocrinology/Hormones
-
靶点ATPase
-
受体Cholesterol side-chain cleavage enzyme; Na+/K+-ATPase
-
研究领域Others
-
适应症Poisoning
化学信息
-
CAS Number20830-75-5
-
分子量780.96
-
分子式C41H64O14
-
纯度>98% (HPLC)
-
溶解度DMSO:78.1 mg/mL (100 mM)
-
SMILESC[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
-
化学全称4-((3S5R8R9S10S12R13S14S17R)-3-(((2R4S5S6R)-5-(((2S4S5S6R)-5-(((2S4S5S6R)-45-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1214-dihydroxy-1013-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ravikumar A et al. Indian J Exp Biol. 2000 May;38(5):438-46.
产品手册
关联产品
-
Acetylcysteine
Acetylcysteine is a derivative of cysteine; an acetyl group that is attached to the nitrogen atom.
-
NDI-091143
NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
-
BRITE338733
BRITE 338733 is a novel inhibitor of ATPase. BRITE 338733 inhibits the expression of RecA in bacteria with IC50 value of 4.7 μM for the bacterial infections treatment.